BioCorRx (BICX) EBITDA (2010 - 2026)
BioCorRx (BICX) posted EBITDA of -$956000.0 for Q1 2026, up 80.93% sequentially from -$5.0 million in Q4 2025, and down 1.92% YoY from -$974762.7 in Q1 2025.
Analysis
BioCorRx (BICX) EBITDA (2010 - 2026) Analysis & Trends
BioCorRx has reported EBITDA for 17 years, with the latest figure at -$956000.0 in Q1 2026.
- Quarterly EBITDA fell 1.92% year-over-year to -$956000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 41.44% YoY) and the FY2025 annual result came in at -$4.8 million, up 5.68% from the prior year.
- EBITDA improved to -$956000.0 in Q1 2026 per BICX's latest filing, from -$5.0 million in the prior quarter.
- Over five years, EBITDA peaked at $180255.0 in Q3 2025 and troughed at -$5.0 million in Q4 2025.
- A 5-year average of -$1.3 million and a median of -$1.1 million in 2023 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 110.86% in 2025, down 345.61% in 2025.
- Over 5 years, EBITDA stood at -$1.2 million in 2022, then soared by 30.62% to -$822712.0 in 2023, then slumped by 36.71% to -$1.1 million in 2024, then sank by 345.61% to -$5.0 million in 2025, then soared by 80.93% to -$956000.0 in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$956000.0, -$5.0 million, and $180255.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -2.55 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 1.50 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 33.50 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 579.00 Mn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 516.68 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 122.50 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 103.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 109.33 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 115.07 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -953,390.00 |
| Dec 31, 2025 | -527,267.00 |
| Sep 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.41 Mn |
| Mar 31, 2025 | -934,182.00 |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | -962,273.00 |
| Dec 31, 2023 | -816,292.00 |
| Sep 30, 2023 | -955,449.00 |
| Jun 30, 2023 | -940,481.00 |
| Mar 31, 2023 | -1.05 Mn |
| Dec 31, 2022 | -1.18 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -1.35 Mn |
| Mar 31, 2022 | -1.12 Mn |
| Dec 31, 2021 | -1.33 Mn |
| Sep 30, 2021 | -1.63 Mn |
| Jun 30, 2021 | -954,441.00 |